Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Asset Writedowns and Impairment (2020 - 2024)

Arcadia Biosciences' Asset Writedowns and Impairment history spans 5 years, with the latest figure at $154000.0 for Q3 2024.

  • For Q3 2024, Asset Writedowns and Impairment fell 38.89% year-over-year to $154000.0; the TTM value through Dec 2025 reached $154000.0, changed 0.0%, while the annual FY2024 figure was $154000.0, 65.32% down from the prior year.
  • Asset Writedowns and Impairment reached $154000.0 in Q3 2024 per RKDA's latest filing, down from $252000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $2.4 million in Q4 2022 to a low of $15000.0 in Q3 2022.
  • Average Asset Writedowns and Impairment over 5 years is $650733.3, with a median of $210000.0 recorded in 2021.
  • The largest YoY upside for Asset Writedowns and Impairment was 1580.0% in 2023 against a maximum downside of 93.75% in 2023.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $1.2 million in 2020, then surged by 49.25% to $1.8 million in 2021, then skyrocketed by 35.57% to $2.4 million in 2022, then plummeted by 89.62% to $252000.0 in 2023, then tumbled by 38.89% to $154000.0 in 2024.
  • Per Business Quant, the three most recent readings for RKDA's Asset Writedowns and Impairment are $154000.0 (Q3 2024), $252000.0 (Q3 2023), and $169000.0 (Q2 2023).